This text is a result of machine translation.
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
China’s OpenAI Challenger Zhipu AI Secures Over CNY 2.5 Billion to Step Further on Large-Scale Model
Maotai Group: it will carry out in-depth cooperation with Mengniu Group in ice cream and other fields
MSCI's rating was upgraded and Mengniu's ESG rating was upgraded to "BBB"
Mengniu Dairy: revenue of 45.91 billion yuan and net profit of 2.95 billion yuan in the first half of the year
China Shengmu: wholly owned subsidiary of China Mengniu increases 12.48% of the company's shares
CICC: Mengniu's medium-term operating profit margin may be improved to maintain the "outperforming industry" rating
Mengniu Dairy: Revenue Falls 5.80% YoY to CNY 37.53 Billion in 1H 2020